Overview/Purpose
This study is being done to try to answer questions about the ways that HIV infection is sometimes well controlled over time. Researchers believe this may have to do with a person's viral load and CD4 count when they started taking anti-HIV medications and genetic factors.
Interested in Volunteering?
This study is enrolling participants who fit one of the following groups:
- Began your anti-HIV medications during the very early part of your HIV infectionOR
- Maintained virologic suppression after stopping ART for 6 months or more ("post-treatment controllers") OR
- Have persistent low-level viremia while on stable ART medications for a year or more
Additionally, you must:
- Be HIV+
- 18 years of age or older
- Have no active Hepatitis B or C infection, history of organ or bone marrow transplant, autoimmune disorder or a condition requiring steroid therapy
- Be taking and planning to continue your current anti-HIV medications (except for "post-treatment controllers"
- Have never stopped your anti-HIV medications for longer than 3 weeks (except for "post-treatment controllers")
Principal Investigator:
Judith S. Currier, MD
For more information, please contact the UCLA CARE Center:
[email protected]
310-843-2015
If you would prefer to have a community outreach coordinator or research coordinator reach out to you, please leave your contact information below and someone will reach out to you shortly.
